GSK3B and diabetic kidney disease: This study breaks through the limitations of single-pathway research, constructing for the first time in podocytes a GSK3β/Nrf2-ERS tripartite crosstalk network, proposing an integrated regulatory model of “metabolism-oxidation-protein homeostasis”, providing a new strategy for DKD treatment.